Skip to Content

Cipla 125 (Topiramate 200 mg)

Pill with imprint Cipla 125 is Pink, Capsule-shape and has been identified as Topiramate 200 mg. It is supplied by Cipla USA Inc..

Topiramate is used in the treatment of epilepsy; seizure prevention; lennox-gastaut syndrome; migraine prevention; seizures and belongs to the drug class carbonic anhydrase inhibitor anticonvulsants. There is positive evidence of human fetal risk during pregnancy. Topiramate 200 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for Cipla 125

Topiramate 200 mg Cipla 125
Topiramate 200 mg Cipla 125
Topiramate 200 mg Cipla 125 Front
Topiramate 200 mg Cipla 125 Back

Topiramate

Imprint
Cipla 125
Strength
200 mg
Color
Pink
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Carbonic anhydrase inhibitor anticonvulsants
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Cipla USA Inc.
National Drug Code (NDC)
69097-0125

Get help with Imprint Code FAQs.

Related Images for "Cipla 125"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.